期刊文献+

胃肠胰神经内分泌肿瘤的认识和问题 被引量:8

Gastroenteropancreatic neuroendocrine neoplasms:concepts and related issues
下载PDF
导出
摘要 神经内分泌肿瘤的发病率逐渐增多,而绝大多数神经内分泌肿瘤发生在胃肠胰。随着近年靶向治疗药物在临床上的应用,临床对病理诊断的要求愈来愈高。正确的靶向治疗首先需要正确的靶向诊断,因此需要临床医师和病理医师形成共识的神经内分泌肿瘤诊断规范。本文阐述了胃肠胰神经内分泌肿瘤的基本概念和百年认识过程;概要呈现神经内分泌肿瘤诊断名称和分级的演化过程;从临床需求出发,胃肠胰神经内分泌肿瘤诊断的八个步骤;本文还对目前病理诊断中尚无统一意见的四个问题进行了讨论,包括病理诊断过程的免疫组织化学标记的选择和应用,高增殖活性亚群神经内分泌肿瘤,普通腺癌神经内分泌分化和分子遗传学特征及靶向治疗。这些问题的正确理解有助于临床神经内分泌肿瘤的诊断和治疗。 The incidence of neuroendocrine neoplasms (NENs) has been gradually increasing and most of NENs are located in gastroenteropancreatic system.With the application of target therapeutic drugs in recent years, the precise pathological diagnosis is required critically for effective clinical treatment: target therapy needs targeted pathological diagnosis.In this article, the definition of NENs, and the century-long evolution of diagnostic terms and grades are reviewed.The eight steps of pathological diagnosis of NENs for clinical needs are described.Four inconsistent concepts in NENs diagnosis are also discussed, that is immunohistochemical biomarkers of pathological diagnosis, subpopulation of neuroendocrine neoplasms with high proliferative activity, general adenocarcinomas with neuroendocrine differentiation and molecular genetics characteristics.To correctly understand these issues would be of great value for diagnosis and treatment of NENs.
作者 来茂德
出处 《浙江大学学报(医学版)》 CAS CSCD 北大核心 2016年第1期5-9,23,共6页 Journal of Zhejiang University(Medical Sciences)
基金 浙江省科技计划项目
关键词 多发性内分泌瘤病/诊断 胃肠肿瘤/诊断 胰腺肿瘤/诊断 生物学标记 免疫组织化学 Multiple endocrine neoplasia/diagnosis Gastrointestinal neoplasms/diagnosis Pancreatic neoplasms/diagnosis Biological markers Immunohistochemistry
  • 相关文献

参考文献3

二级参考文献24

  • 1Hamilton S R,Aaltonen L A.World Health Organization classification of tumours of the digestive system[M].Lyon:IARC Press,2000:1-193.
  • 2Bosman F T,Carneiro F,Hruban R H,et al.World Health Organization classification of tumours of the digestive system[M].Lyon:IARC Press,2010:1-155.
  • 3Simona Gurzu,Orsolya Serester,Ioan Jung.Possible Neuroendocrine Phenotype of Poorly Differentiated Cell Clusters in Colorectal Carcinoma, as a Prognostic Parameter[J]. The American Journal of Surgical Pathology . 2014 (1)
  • 4Yao James C,Shah Manisha H,Ito Tetsuhide,Bohas Catherine Lombard,Wolin Edward M,Van Cutsem Eric,Hobday Timothy J,Okusaka Takuji,Capdevila Jaume,de Vries Elisabeth G E,Tomassetti Paola,Pavel Marianne E,Hoosen Sakina,Haas Tomas,Lincy Jeremie.Everolimus for advanced pancreatic neuroendocrine tumors. The New England Quarterly . 2011
  • 5Raymond Eric,Dahan Laetitia,Raoul Jean-Luc,Bang Yung-Jue,Borbath Ivan,Lombard-Bohas Catherine,Valle Juan,Metrakos Peter,Smith Denis,Vinik Aaron,Chen Jen-Shi,H?rsch Dieter,Hammel Pascal,Wiedenmann Bertram,Van Cutsem Eric,Patyna Shem,Lu Dong.Sunitinib malate for the treatment of pancreatic neuroendocrine tumors. The New England Quarterly . 2011
  • 6Autumn J. McRee,Janine M. Davies,Hanna G. Sanoff,Richard M. Goldberg,Stephen Bernard,E. Claire Dees,Kimberly Keller,Anastasia Ivanova,Bert H. O’Neil.A phase I trial of everolimus in combination with 5-FU/LV, mFOLFOX6 and mFOLFOX6 plus panitumumab in patients with refractory solid tumors[J]. Cancer Chemotherapy and Pharmacology . 2014 (1)
  • 7Yue Liu,Jinghong Xu,Yurong Jiao,Yeting Hu,Chenghao Yi,Qiong Li,Zhou Tong,Xiaowei Wang,Lifeng Hu,Qian Xiao,Jun Li,Kefeng Ding,Hanlin L. Wang.Neuroendocrine Differentiation Is a Prognostic Factor for Stage II Poorly Differentiated Colorectal Cancer[J]. BioMed Research International . 2014
  • 8Alessandro Scopelliti,Julia B. Cordero,Fengqiu Diao,Karen Strathdee,Benjamin H. White,Owen J. Sansom,Marcos Vidal.Local Control of Intestinal Stem Cell Homeostasis by Enteroendocrine Cells in the Adult Drosophila Midgut[J]. Current Biology . 2014 (11)
  • 9Christine A. Ciunci,Rodolfo F. Perini,Anjali N. Avadhani,Hyunseon C. Kang,Weijing Sun,Maryann Redlinger,Kathleen Harlacker,Keith T. Flaherty,Bruce J. Giantonio,Mark A. Rosen,Chaitanya R. Divgi,Hee Kwon Song,Sarah Englander,Andrea Troxel,Mitchell Schnall,Peter J. O’Dwyer.Phase 1 and pharmacodynamic trial of everolimus in combination with cetuximab in patients with advanced cancer[J]. Cancer . 2014 (1)
  • 10Zhi Rong Qian,Monica Ter-Minassian,Jennifer A. Chan,Yu Imamura,Susanne M. Hooshmand,Aya Kuchiba,Teppei Morikawa,Lauren K. Brais,Anastassia Daskalova,Rachel Heafield,Xihong Lin,David C. Christiani,Charles S. Fuchs,Shuji Ogino,Matthew H. Kulke.Prognostic Significance of MTOR Pathway Component Expression in Neuroendocrine Tumors[J]. Journal of Clinical Oncology . 2013 (27)

共引文献256

同被引文献77

引证文献8

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部